Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
about
The trans-kingdom identification of negative regulators of pathogen hypervirulenceAll you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious diseasePromoter-Specific Transcription Inhibition in Staphylococcus aureus by a Phage ProteinStructures of Helicobacter pylori Shikimate Kinase Reveal a Selective Inhibitor-Induced-Fit MechanismMolecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureusFrequency and antibiotic susceptibility of gram-positive bacteria in Makkah hospitalsDaptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responsesMicrobial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementationPostgenomic strategies in antibacterial drug discovery.Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and preventionWar on terror cells: killing the host that harbours 'superbugs' is an infection control strategy in our fight against infectious diseases.A high throughput flow cytometric assay platform targeting transporter inhibitionRapid detection of Pseudomonas aeruginosa from positive blood cultures by quantitative PCR.Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.Checks and balances: the ocular response to infection.Response of corneal epithelial cells to Staphylococcus aureus.RNA-Seq reveals differential gene expression in Staphylococcus aureus with single-nucleotide resolutionMicropatterned surfaces for reducing the risk of catheter-associated urinary tract infection: an in vitro study on the effect of sharklet micropatterned surfaces to inhibit bacterial colonization and migration of uropathogenic Escherichia coliPopulation biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistancePrevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing.Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases.Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue.Economics of antibiotic resistance.Methicillin-resistant Staphylococcus aureus in Zimbabwe.Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyondNew trends in pharmacogenomic strategies against resistance development in microbial infections.Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.Antimicrobial resistance pattern of Gram-positive bacteria during three consecutive years at the nephrology ward of a tertiary referral hospital in Shiraz, Southwest Iran.Animals living in polluted environments are potential source of antimicrobials against infectious agents.A new vision of immunity: homeostasis of the superorganism.Strategies to manage antifungal drug resistance.Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.The 'liaisons dangereuses' between iron and antibiotics.Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection.Antimicrobial Activity of Bacillus amyloliquefaciens ANT1 Toward Pathogenic Bacteria and Mold: Effects on Biofilm Formation.Characterization of the tertiary structure of the peptidoglycan of Enterococcus faecalis.Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana).Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.
P2860
Q26782915-46C21615-FB1F-4480-A988-48BF5FB39F8DQ26830053-D412854D-B728-43B8-892A-F772F617DA93Q27675215-56EC157A-C7BB-44CD-AE02-88395C1744FBQ27678149-D6012FBE-49C8-4D30-B109-29E9FECE05E8Q28078930-01D08912-53A6-4399-B9F9-65AB87DB7A7DQ28392343-9EBC7AB4-F8DA-4AE6-BD90-483982A7BFBCQ28754911-91BFA949-428B-449B-9CC2-A522EAE2CA1CQ33355620-2650915B-3814-402C-8AD7-6BB476278A93Q33745572-6E5C2AC1-661E-4795-8BAF-B8E32A9017F5Q33828309-93ADF27E-83F5-4442-8FE6-058271B38F34Q33850836-04DFAAF7-ECC9-41D5-A3A1-6FD2E1AB1B6DQ33912745-151526F9-E730-43CA-8E8A-3C4269F7158AQ34086132-75C08621-DC8C-40D6-809B-E4194B82F311Q34365963-41697439-C6D1-43EF-B793-13BDA41F612FQ34775530-AA35FD2A-AD20-4522-AD37-6BB71531CE4CQ34775535-7D8F295A-F63F-4446-827C-6B92E49C92D5Q35014723-2E4F1551-78E6-47DE-991F-DC8F98082E4EQ35202194-E5873F7B-86C3-4B8B-8D7D-8A12F776E7FEQ35622545-E6717189-880A-423D-9505-CCE973E42CBDQ36396130-039F0CE6-3A9F-484D-8A50-E3B8CE5725BBQ36571855-0293E005-DB88-4F15-9CD0-FBB2AEA6D801Q37077611-7A55D3EC-56E5-48A1-B5FC-EE93523D144AQ37137221-3185C2EA-1622-42D9-AE0E-09295CF84B9EQ37228745-ED564823-91AC-420F-A214-591C083AE0B3Q37233727-226509F8-408A-4C49-9602-FD4B9E0EFF18Q37318721-773A8F24-0C6A-451D-A775-2E0DF329757FQ37329167-7B10B25A-7514-4822-A0E9-A61250469047Q37333114-0E927050-C765-4A09-8E86-BCA9B34B41AAQ37374748-C60148F6-3DA0-48D9-8C80-603429C01649Q37726760-A57D41AF-F5E1-45E0-9744-C486BC600D37Q37743152-C83E5F2D-FEBB-41D2-B174-ABEC25493FDAQ37827872-09861E9A-72D9-4497-9C3A-071E07392520Q38625299-B9B321ED-9EEB-4B25-8B89-778F2F8A571FQ38761978-D1042F4B-9387-4416-86F5-AAEEFE1714C9Q38842620-14CB3E37-44CB-468F-9946-C6D1FDBA0B70Q38977280-706F54D1-BCF0-4227-A8D6-5AA7CF8DF8C9Q40090942-E392E605-126A-411F-B097-A660CFB95407Q40103359-2BB78A3B-124F-4CDB-81D2-0B8904483D06Q40506281-EA44BB99-6A74-433E-9772-F1FB18574AF6Q40772570-3DF0A378-FAB8-4370-94B2-E962430606B3
P2860
Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Superbugs in the coming new de ...... seudomonas aeruginosa in 2010.
@en
type
label
Superbugs in the coming new de ...... seudomonas aeruginosa in 2010.
@en
prefLabel
Superbugs in the coming new de ...... seudomonas aeruginosa in 2010.
@en
P50
P1476
Superbugs in the coming new de ...... seudomonas aeruginosa in 2010.
@en
P2093
Nicolas Fortineau
P304
P356
10.1016/J.MIB.2007.07.004
P577
2007-08-30T00:00:00Z